Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease

Journal of Laboratory and Clinical Medicine

Volumn 137, Issue 1, 2001, Pages 5-13

  Brown, Paul ^a,b,c   Cervenáková, Larisa ^a,b,c   Diringer, Heino ^a,b,c  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b AMERICAN RED CROSS   (United States)

^c ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0035138695     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2001.111951     Document Type: Article

References (37)

1. Can Creutzfeldt-Jakob disease be transmitted by transfusion?
2. Transmissible mink encephalopathy: Studies on the peripheral lymphocyte
3. Transmissible mink encephalopathy: Behavior of the disease agent in mink
4. BSE transmission studies with particular reference to blood
5. Studies of BSE infectivity in tissues of cattle. Presented at a Joint Meeting of TSE/VRBP Advisory Committees, Bethesda, Maryland, July 27
6. The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy
7. Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans
8. Infectivity in the blood of mice with a BSE-derived agent
9. Transmission of BSE by blood transfer in sheep
10. Assessment of the potential of plasma fractionation processes to remove causative agents of transmissible spongiform encephalopathy
11. Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein
12. Studies on the removal of abnormal prion protein by processes used in the manufacture of human plasma products
13. A direct relationship between partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins
14. Creutzfeldt-Jakob disease and blood transfusion
15. Risk factors for Creutzfeldt-Jakob disease: A reanalysis of case-control studies
16. Creutzfeldt-Jakob disease in the United States, 1979-1994: Using National Mortality data to assess the possible occurrence of variant cases
17. European surveillance on Creutzfeldt-Jakob disease: A case-control study for medical risk factors
18. Creutzfeldt-Jakob disease and blood transfusion
19. Surveillance for Creutzfeldt-Jakob disease among persons with hemophilia
20. Molecular analysis of prion strain variation and the aetiology of "new variant" CJD
21. Transmissions to mice indicate that "new variant" CJD is caused by the BSE agent
22. Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans
23. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples
24. Isolation and structural studies of the intact scrapie agent protein
25. Highly infectious purified preparations of disease-specific amyloid of transmissible spongiform encephalopathies are not devoid of nucleic acids of viral size
26. Human spongiform encephalopathy: The National Institutes of Health series of 300 cases of experimentally transmitted disease
27. A diagnostic test for scrapieinfected sheep using a capillary electrophoresis immunoassay with fluorescent-labeled peptides
28. Use of capillary electrophoresis and fluorescent labeled peptides to detect the abnormal prion protein in the blood of animals that are infected with a transmissible spongiform encephalopathy
29. Eight prion strains have PrPsc molecules with different conformations
30. Application of a time-resolved fluoroimmunoassay for the analysis of normal prion protein in human blood and its components
31. Immunochemical determination of cellular prion protein in plasma from healthy subjects and patients with sporadic Creutzfeldt-Jakob disease or other neurological diseases
32. A cell surface receptor for the prion protein
33. sc by multi-spectral ultraviolet fluorescence
34. Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluoresecent targets
35. Immuno-PCR: Very sensitive antigen detection by means of specific antibody-DNA conjugates
36. Fluorometric polymerase chain reaction (PCR) enzyme-linked immunosorbent assay for quantification of immuno-PCR products in microplates